Design and Optimization of Rosuvastatin Calcium Orally Fast Disintegrating Tablet Using Artificial Neural Network Based on Multilayer Perceptron Model

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 90

فایل این مقاله در 18 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JMCH-7-10_003

تاریخ نمایه سازی: 13 آبان 1403

چکیده مقاله:

The purpose of the current study is to design and optimize Rosuvastatin calcium orally fast disintegrating tablet (OFDT) with the assistance of an Artificial Neural Network (ANN) based Multi-layer Perceptron (MLP) model. Rosuvastatin calcium is commonly employed as a cholesterol-lowering agent. In our previous work established literature raw material data of OFDTs were collected from ۹۲ research articles, which contain compositional and evaluation parameters and the data trained with Machine learning techniques (ML) to evaluate the optimal ingredients which helps further to develop and optimize Rosuvastatin calcium OFDTs using ANN based MLP. Rosuvastatin calcium OFDTs were formulated according to a ۳۲-factorial design (randomized Box-Behnken method), and formulations were compressed using the direct compression method with varying compositions of superdisintegrant (Crospovidone) ۲-۴% binder microcrystalline cellulose (MCC) ۵-۲۰%, Mannitol as a diluent, magnesium stearate (Mg st) as a lubricant, and talc (۱-۳%) as a glidant. The developed formulations were assessed to determine their thickness, hardness, friability, disintegration time, and drug content. ANN was used for optimization, and the MLP model was trained using experimental data until a satisfactory R۲ of ۰.۹۹ and normalized root mean square error (NRMSE) of ۰.۰۲۴ was reached. The compressed tablets (F۱۹) exceeded the desired criteria in terms of thickness (۲.۶mm), hardness (۲.۸ kg), friability (۰.۶%), drug content (۹۹%), and disintegration time (۳۶ sec). The potential use of ANN in pharmaceutical formulation optimization to achieve desired performance characteristics is demonstrated by this work. This study shows the efficacy of ANN with MLP in the development of Rosuvastatin calcium OFDTs.

نویسندگان

Navyaja K.

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy. SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu- ۶۰۳۲۰۳, India

Kamaraj R.

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy. SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu- ۶۰۳۲۰۳, India

Bharathi M.

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy. SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu- ۶۰۳۲۰۳, India

Sudheer Kumar T.

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy. SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu- ۶۰۳۲۰۳, India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • . Sunada H., Bi Y., Preparation, evaluation and optimization of ...
  • . Kota N., Kamaraj R., Murugaanandam S., Bharathi M., Kumar ...
  • . Purkayastha H.D., Nath B., Formulation and evaluation of oral ...
  • . Bala R., Khanna S., Pawar P.K., Formulation and optimization ...
  • . Wang S., Di J., Wang D., Dai X., Hua ...
  • . Abdipoor A., Taheri A., Rangin A., New magnetic graphene ...
  • . Mahmoodnezhad D., Taheri A., Development of a new methodology ...
  • . Chaibva F., Burton M., Walker R.B., Optimization of salbutamol ...
  • . Kar M., Chourasiya Y., Maheshwari R., Tekade RK., Current Developments in Excipient ...
  • . a) Silalahi, C., Andarsini, M.R., Cahyadi, A. Unveiling risk ...
  • b) Pabari R., Ramtoola Z., Effect of a disintegration mechanism ...
  • . Khan M.Z., Yousuf R.I., Shoaib M.H., Ahmed F.R., Saleem ...
  • . Mandal U., Gowda V., Ghosh A., Bose A., Bhaumik ...
  • . Dong Y., Yang T., Xing Y., Du J., Meng ...
  • . González R., Peña M.Á., Torres N.S., Torrado G., Design, ...
  • . Vivarelli M., Montalti R., Risaliti A., Multimodal treatment of ...
  • . Velivela S., Mayasa V., Guptha R., Pati N.B., Ramadevi ...
  • . Almotairi N., Mahrous G.M., Al-Suwayeh S., Kazi M., Design ...
  • . Başkor A., Tok Y.P., Mesut B., Özsoy Y., Uçar ...
  • . Akseli I., Cetinkaya C., Drug tablet thickness estimations using ...
  • . Gordon M.S., Process considerations in reducing tablet friability and ...
  • . Wilson K.E., Crossman E., The influence of tablet shape ...
  • . Tahraoui H., Amrane A., Belhadj A.-E., Zhang J., Modeling ...
  • . Yeğen G., Aksu B., Cevher E., Design of an ...
  • . Caramella C., Colombo P., Conte U., Gazzaniga A., La ...
  • . Shu T., Suzuki H., Hironaka K., Ito K., Studies ...
  • . Aksu B., Yegen G., Purisa S., Cevher E., Ozsoy ...
  • . Vu G.T.T., Phan N.T., Nguyen H.T., Nguyen H.C., Tran ...
  • نمایش کامل مراجع